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Liposome fusionThe reovirus p10 fusion-associated small transmembrane (FAST) proteins are the smallest knownmembrane fusion
proteins, and evolved speciﬁcally to mediate cell–cell, rather than virus–cell, membrane fusion. The 36–40-residue
ectodomains of avian reovirus (ARV) and Nelson Bay reovirus (NBV) p10 contain an essential intramolecular
disulﬁde bond required for both cell–cell fusion and lipid mixing between liposomes. To more clearly deﬁne the
functional, biochemical and biophysical features of this novel fusion peptide, synthetic peptides representing the
p10 ectodomains of ARV and NBV were analyzed by solution-state NMR spectroscopy, circular dichroism spectros-
copy, ﬂuorescence spectroscopy-based hydrophobicity analysis, and liposome binding and fusion assays. Results
indicate that disulﬁde bond formation promotes exposure of hydrophobic residues, as indicated by bis-ANS binding
and time-dependent peptide aggregation under aqueous conditions, implying the disulﬁde bond creates a small,
geometrically constrained, cystine noose. Noose formation is required for peptide partitioning into liposome
membranes and liposome lipid mixing, and electron microscopy revealed that liposome–liposome fusion occurs
in the absence of liposome tubulation. In addition, p10 fusion peptide activity, but not membrane partitioning, is
dependent on membrane cholesterol.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Fusion of two cell membranes is an important step in many essential
biological processes, such as fertilization, formation of the syncytio-
trophoblast layer of the placenta,myoblast fusion duringmuscle develop-
ment, and formation of osteoclasts for bone resorption [1]. Membrane
fusion is also an essential step in the infection of host cells by envelopedavian reovirus; bis-ANS, 4,4′-
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uncan@dal.ca (R. Duncan).viruses, such as HIV and inﬂuenza [2]. Such membrane merger events
are energetically unfavorable processes and require protein fusogens to
mediate fusion of biological membranes under physiological conditions.
In the case of enveloped virus fusion proteins, the process involves
triggered, complex structural rearrangements of the fusion proteins.
These conformational changes expose a hydrophobic sequence known
as the fusion peptide (FP), which is normally sequestered from solvent
within the pre-fusion structure. Formation of an extended intermediate
projects the FP toward the target membrane for membrane insertion.
Folding back of this extended intermediate into a compact trimeric
hairpin structure is believed to provide energy to pull the apposed
membranes together and drive membrane merger [3]. Exactly how
membrane fusion proteins mediate the actual merger of membranes,
and the precise role of FPs in this process, is still unclear.
While extensive structural remodeling of enveloped virus fusion
proteins is clearly a key event in the fusion process, it seems likely
that FPs serve a greater role in promoting membrane merger than just
serving as membrane anchors [4]. There are two general classes of
enveloped virus FPs. The ﬁrst are N-terminal FPs in proteins such as
inﬂuenza virus hemagglutinin (HA) and HIV gp41, which form amphi-
pathicα-helices that are frequently kinked or in a helical hairpin confor-
mation, exposing hydrophobic faces for membrane insertion [5–7]. The
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such as dengue virus E1 and Ebolavirus gp2 [8,9]. These loops areﬂanked
by elongated, anti-parallelβ-strands and expose hydrophobic residues at
the apex of the loop for membrane insertion. The prevailing view is that
FPs shallowly insert into the outer leaﬂet ofmembrane bilayers, inducing
membrane bending that results in formation of a dimple. Dimple forma-
tion would promote close membrane apposition, with membrane bend-
ing stresses in the highly curved lipidic cap of the dimple being relieved
bymembrane merger [10]. Support for this model of FP function derives
from studies of cellular proteins involved in vesicle fusion. For example,
shallow insertion of an amphipathic helix in the endophilin N-BAR do-
main or hydrophobic loops in the C2 domains of synaptotagmin and
Doc2b proteins induce extensive membrane curvature resulting in lipo-
some tubulation and generation of highly fusogenic lipidic end caps on
these tubules [11–15]. Whether viral FPs induce liposome fusion via a
similar tubulation mechanism has not been determined.
In addition to enveloped viruses, a single family of nonenveloped
viruses also encodes membrane fusion proteins. The fusion-associated
small transmembrane (FAST) proteins are encoded by the fusogenic
Aquareoviruses and Orthoreoviruses, two genera in the family Reoviridae,
a large diverse group of nonenveloped viruses with segmented, dsRNA
genomes [16]. FAST proteins are nonstructural viral proteins expressed
inside virus-infected cells, where they trafﬁc to the plasma membrane
to induce cell–cell membrane fusion and syncytium formation [17]. All
FAST proteins are integral membrane proteins, with a single transmem-
brane domain separating very small (~20–40 residues) N-terminal
ectodomains from equal-sized or considerably larger C-terminal
cytoplasmic endodomains [18–23]. The homologous p10 FAST proteins
of avian (ARV) and Nelson Bay (NBV) orthoreoviruses, and the unre-
lated p14 and p15 FAST proteins of reptilian (RRV) and baboon
orthoreoviruses, respectively, all contain motifs in their small
ectodomains that share features with canonical viral FPs [17].
These FP motifs are essential for cell–cell fusion, and synthetic pep-
tides based on these motifs induce liposome–liposome lipid mixing.
Structurally, these motifs differ dramatically from each other, and
from enveloped virus FPs. An intramolecular disulﬁde bond in p10
creates an 11-residue cystine loop FP, the p14 FP contains a 7-
residue proline-hinged loop, while the 19-residue p15 ectodomain
FP comprises a polyproline type II helix ﬂanked by short, amphiphil-
ic, unstructured regions [24–26]. Aside from being essential for cell–
cell fusion and inducing lipid mixing between liposomes, these atyp-
ical FAST protein FPs remain poorly characterized.
At 95–98 residues in size, the p10 FAST proteins encoded by avian
and bat reoviruses are the smallest known viral or cellularmembrane fu-
sion proteins. We recently reported the presence of a cystine loop FP in
ARV and NBV p10, and showed stringent sequence constraints within
and ﬂanking the cystine loop affect formation of the intramolecular
disulﬁde bond [27]. Speciﬁc features of the p10 cystine loop are quite dis-
tinct from enveloped virus fusion loops. For example, the enveloped
virus fusion loops are located at the tips of disulﬁde-stabilized structures
comprising anti-parallel β-strands [9,28] or in order-turn-order struc-
tures [29,30]. In some cases, such as Ebola virus gp2, the fusion loop is ac-
tually partly helical [31,32]. Enveloped virus FPs that function as fusion
loops are therefore components of larger structures, and the role of disul-
ﬁde bonds is to stabilize the overall fusion domain rather than the FP di-
rectly. In contrast, the p10 ectodomain is only 36–40 residues in size, and
the 11-residue fusion loop is self-contained within a 15–19 residue se-
quence that is solely required for formation of the cystine loop FP [27].
We now show that formation of the p10 intramolecular disulﬁde bond
forces solvent exposure of hydrophobic residues, suggesting the cystine
loop functions as a cystine noose [33]. Cystine noose formation is re-
quired for membrane partitioning, structural transitions and fusion ac-
tivity. Additionally, we demonstrate that p10-induced liposome-
liposome fusion occurs in the absence of liposome tubulation, and that
cholesterol is required for the post-binding lipid mixing stage of p10-
mediated membrane fusion.2. Materials and methods
2.1. Synthetic peptides
Peptides corresponding to the ectodomain (residues 1–40) of the ARV
p10 protein (ARV p10ecto) were synthesized by Genscript to contain an
intramolecular disulﬁde bond between Cys9 and Cys21. Peptides corre-
sponding to a partially truncated (residues 4–36) ARV p10 ectodomain
(p10ectoTr) and to the NBV p10 ectodomain (residues 1–35, NBV
p10ecto) were synthesized by United Peptide to contain a similar intra-
molecular disulﬁde bond. A similar NBV p10ecto peptide containing a
Ser substitution of Cys5 (NBV p10C5ecto) to prevent formation of the di-
sulﬁde bond was also synthesized by United Peptide. All peptides were
puriﬁed to 95% purity by HPLC and conﬁrmed by mass spectrometry.
2.2. Hydrophobicity and aggregation analysis
Hydrophobicity predictions were performed with Protscale on the
ExPASy server, using a sliding window average of 5 residues. Relative
hydrophobicity was measured in aqueous conditions (10 mM NaPO4,
100 mM NaF, pH 7.4) using 4.7 μM 4,4′-dianilino-1,1′-binaphthyl-5,5′-
disulfonic acid (bis-ANS, Invitrogen) and 80 μM of a given p10
ectodomain peptidewith andwithout 20mMtris(2-carboxyethyl)phos-
phine (TCEP). Steady-state ﬂuorescence spectroscopy was performed
using a Varian Cary Eclipse spectroﬂuorometer at 35 °C in a 3mmquartz
cuvette (Varian), with excitation and emission slit widths of 5 nm. Emis-
sion spectra were measured from 460 to 600 nm with an excitation
wavelength of 360 nm. Time-dependent aggregation of the p10ecto
peptide (0.5 mM), in aqueous conditions (10 mM NaPO4, 100 mM NaF,
pH 7.4) with and without 5 mM dithiothreitol (DTT), was followed by
OD350measurements using a Varian Cary 50 UV/Vis spectrophotometer.
All spectra were background subtracted. Bis-ANS experiments were
repeated in quadruplicate, while peptide aggregation experiments were
performed in triplicate.
2.3. Solution-state nuclear magnetic resonance (NMR) spectroscopy
Solution-state NMR experiments were performed on the p10ectoTr
peptide in the organic solvents dimethyl sulfoxide (DMSO-d6) and
hexaﬂuoro-2-propanol (HFIP-d2), and in the sodium dodecylsulfate
(SDS-d25) and dodecylphosphocholine (DPC-d38) membrane-micellar
mimetic environments. Organic solvent samples were prepared by
dissolving the peptide (~0.5 mM) in 100% DMSO-d6 or 50% HFIP-d2
plus 40% H2O and 10% D2O. Micelle samples were prepared by dissolv-
ing the peptide in SDS-d25 or DPC-d38 (150 mM) in 90% H2O and 10%
D2O, and adjusting the pH to 5.0. The HFIP, SDS and DPC samples also
contained 0.5 mM sodium 2,2-dimethyl-2-silapentane-5-sulfonate
(DSS) and 0.2 mM sodium azide. The SDS and DPC samples were buff-
ered with 20 mM sodium acetate (pH 5.0). NMR data were acquired
using a Bruker Avance III 700 MHz spectrometer equipped with a
5 mm triple-resonance inverse cryoprobe and processed using Bruker
Topspin 3.1. 1D 1H, 2D 1H–1H total correlation spectroscopy (TOCSY;
number of scans 16, size of ﬁd 2048/512 in F2(1H)/F1(1H), sweep
width 12/12 ppm in F2/F1, recycle delay 2 s, mixing time 60/120 ms,
DIPSI2 isotropic mixing sequence) and 2D 1H–1H nuclear Overhauser
enhancement spectroscopy (NOESY; number of scans 16, size of ﬁd
2048/512 in F2(1H)/F1(1H), sweep width 12/12 ppm in F2/F1, recycle
delay 2 s, mixing time 200–400 ms) spectra were acquired for the
p10ectoTr peptide under all four solvent conditions at 22 and 37 °C.
Spectra collected in HFIP, SDS and DPC were referenced to internal
DSS at 0 ppm. Spectra collected in DMSO were indirectly referenced to
0 ppm for aqueous DSS using the intermediate trimethylsilane (TMS)
shift. Spin system assignment was performed, to the extent possible,
in Sparky 3.110 (Goddard, T.D., and Kneller, D.G. Sparky 3, University
of California, San Francisco). Secondary chemical shifts (Δδ) for Hα
resonances of unambiguously identiﬁed residues were calculated by
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GGXAGG measured in DMSO [34] from those measured in p10ectoTr.
2.4. Circular dichroism (CD) spectropolarimetry
Far-UV (260–185 nm) CD spectra of p10ecto peptide were recorded
using a Jasco J-810 spectropolarimeter (Easton, MD) at 35 °C using
0.01 cm quartz cuvettes (Hellma, Müllheim, Germany). Spectra were
obtained using 0.05 mg ARV p10 ectodomain peptide, with or without
reduction by 5 mM DTT, in aqueous solution (10 mM NaPO4, 100 mM
NaF) or in the presence of 100 mM liposomes (40:30:20:10 molar
ratio of 1,2-dioleoyl-sn-glycero-3-phosphocholine [DOPC]:1,2-dioleoyl-
sn-glycero-3-phosphoethanolamine [DOPE]:cholesterol [Chol]:
sphingomylein [Sph]; 100 nm diameter). Six replicate spectra were
acquired in 0.1 nm steps and the raw data, averaged, blank subtracted,
converted tomean residue ellipticity [θ] and averaged using a weighted
3 nm sliding-window.
2.5. Lipid mixing assay
A ﬂuorescence resonance energy transfer (FRET)-basedmixing assay
was employed to monitor the lipid-mixing potential of synthetic p10
ectodomain peptides [35]. Liposomes composed of a constant 30 mol%
DOPE and the indicated amounts of DOPC, Chol and Sph (Avanti Polar
Lipids) in 10 mM NaPO4, 100 mM NaF, pH 7.4, were prepared and
extruded to 100 nm as previously described [26]. A ﬂuorescently-
labeled liposome population was similarly prepared to contain 2 mol%
each of 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(7-nitro-2-
1,3-benzoxadiazol-4-yl) (NBD-DOPE) and 1,2-dioleoyl-sn-glycero-3-
phosphoethanolamine-N-4(lissamine rhodamine B sulfonyl) (Rho-
DOPE). Non-labeled and labeled liposomes at a ﬁnal concentration of
100 μM were incubated at 37 °C in a 9:1 ratio prior to addition of
p10ecto synthetic peptide (10 μM) or buffer only control (10 mM
NaPO4, 100 mM NaF, pH 7.4). Fluorescence emission was recorded for
up to ten minutes at 37 °C using an excitation wavelength of 460 nm
and an emissionwavelength of 535 nmon a Varian Cary Eclipseﬂuores-
cent spectrophotometer. A third liposome population containing
0.2 mol% each of NBD-DOPE and Rho-DOPE was measured identically
to determine the theoretical maximum (FMAX) level of lipid mixing.
The percent lipid mixing was calculated as previously shown [26]. All
experiments were performed in quadruplicate.
2.6. Peptide partitioning into liposome membranes
Liposomes (100 nm diameter) of a constant 30% DOPE and 10% Sph
composition, containing a given proportion of Chol and the correspond-
ing proportion of DOPC, were incubated in a 1:10 ratio with p10ecto
peptide (125 μM) in 250 μL of 10 mM NaPO4, 100 mM NaF, pH 7.4, with
orwithout 5mMDTT. Samplesweremixedwith an equivalent volume of
60% sucrose, then successively overlaid with 800 μL of 20% sucrose and
100 μL of buffer. Samples were centrifuged at 50 K rpm for 45 min at
4 °C in a Beckman SW60 Ti rotor (256,000 ×g), the liposome-containing
fraction at the 20%–0% sucrose interface was harvested and mixed with
2× protein sample buffer (20%SDS, glycerol, Tris–HCl, pH 6.8), and
p10ecto peptide detected by tricine SDS-PAGE and silver staining.
2.7. Electron microscopy
Liposomes (100 nm diameter) composed of 40:30:20:10 of DOPC:
DOPE:Chol:Sph (100 μM) were incubated with buffer alone (10 mM
NaPO4, 100mMNaF, pH 7.4), ARV p10 or NBVp10 ectodomain peptides
(10 μM) for 5 min at 37 °C. Samples were settled on to Formvar/carbon
coated grids, stained with 2% uranyl acetate, and visualized on a JEOL
JEM1230 transmission electronmicroscope. Liposome sizeswere deter-
mined by measuring diameters of at least 900 liposomes present in
ﬁve random ﬁelds from two separate experiments at 50–80,000×magniﬁcation using ImageJ. Liposome sizes were binned and presented
as percent liposomes in each bin size, or as percent total liposome
volume in each bin size, calculated by dividing the sum of liposome
volumes in each bin by the total volume of liposomes.
3. Results and discussion
3.1. Cystine loop formation forces solvent exposure of hydrophobic residues
and causes aggregation of the p10 ectodomain
The NBV and ARV p10 ectodomains are 36 or 40 residues in length,
respectively (Fig. 1A). The C-terminal 13 residues of each ectodomain
contain a 9-residue conserved motif (CM), which is present in all p10
proteins from both avian and pteropine reoviruses and is responsible
for cholesterol-dependent p10 multimerization [27]. The cystine loop
FP is N-terminal to the CM, spanning Cys9–Cys21 in ARV p10 and
Cys5–17 in NBV p10. Loop formation is inﬂuenced by residues immedi-
ately ﬂanking the two cysteines but is unaffected by the membrane-
proximal multimerization motif [27]. Seven of the eleven amino acids
in the p10 cystine loops are hydrophobic or apolar, with NBV p10
being slightly more hydrophobic than ARV p10 (Fig. 1A). Both proteins
contain a conserved Val-Phe dipeptide at the apex of their loops. Polar
residues in the loop are tolerant of substitution, while hydrophobic
residues are intolerant of even minor changes in hydrophobicity, with
a clear preference for Phe or Trp at the apex of the loop [36,37].We pre-
viously speculated that the cystine loop might function as a cystine
noose, a short disulﬁde-stabilized loop structure [33], to force solvent
exposure of hydrophobic residues in the p10 FP [24].
To explorewhether the p10 FP functions as a cystine noose, a synthet-
ic peptide representing the 40-residue ARV p10 ectodomain (Fig. 1A)
was commercially synthesized to include the essential intramolecular
disulﬁde bond between Cys9 and Cys21, which creates the essential cys-
tine loop [24]. A similar peptide of the 36-residue NBV p10 ectodomain
(Fig. 1A) was also synthesized containing an intramolecular disulﬁde
bond. The hydrophobicity of these peptides was directly assessed using
bis-ANS. Anilinonaphthalene sulfonates (ANS) are nonﬂuorescent in
polar solvents but exhibit strong ﬂuorescence when bound to apolar
molecules, and are commonly employed as probes sensitive to solvent
exposure of hydrophobic amino acids [38]. As shown (Fig. 1B), the
loop-containing ARV and NBV peptides both induced bis-ANS ﬂuores-
cence, which was substantially decreased when the disulﬁde bond was
reduced by TCEP. In addition, the presence ofmore hydrophobic residues
within the NBV loop (Fig. 1A) correlated with increased bis-ANS ﬂuores-
cence inducedby theNBVpeptide (Fig. 1B). To ensure the reducing agent
had no intrinsic effect on bis-ANS ﬂuorescence, the NBV p10ecto was
compared to the same peptide containing a Ser substitution of Cys5
(NBV p10C5ecto). The mutant peptide in the absence or presence of
TCEP displayed a similar reduction in bis-ANS ﬂuorescence as the
reduced parental peptide (Fig. 1C). The disulﬁde bond therefore substan-
tially increases the hydrophobicity of the ARV and NBV FPs.
Although the ARV p10ecto peptide was soluble at a concentration of
0.5 mM under aqueous conditions (conditions compatible with NMR
analysis), measurement of light scattering at 350 nm demonstrated
time-dependent peptide aggregation with a lag phase of ~15 h before
a rapid increase in scattering (Fig. 1D). A similar situation occurred
with a slightly truncated version of the ARV p10 ectodomain peptide
(p10ectoTr), missing the N-terminal Met-Leu-Arg and C-terminal Ser-
Ile-Ile-Ala residues, as well as with synthetic peptides of the NBV p10
ectodomain (data not shown). Disruption of the intramolecular disul-
ﬁde bondwith 5 mMDTT prevented aggregation in aqueous conditions
(Fig. 1D). The long lag phase prior to peptide aggregation suggests that
simple hydrophobic interactions alone may not account for peptide
aggregation at concentrations suitable for NMR. Peptide aggregation is in-
ﬂuenced by peptide hydrophobicity, secondary structure propensity, sur-
face charge density, andmonomer concentrations [39,40]. Time scales for
aggregation can range from μs for proteins such as the human islet
Fig. 1. The p10 disulﬁde bond forces exposure of hydrophobic residues. (A) Sequence alignment of the ARV and NBV p10 ectodomains (top), indicating the locations of the cystine loop fusion
peptide (FP) and conservedmotif (CM). Numbers indicate residue positions in theARV sequence. Predicted hydrophobicity of linearARV andNBVp10 ectodomains (bottom)basedonKyte and
Doolittle hydrophobicity scale using sliding window averages of 5 residues. (B) Fluorescence emission spectra (λex = 360 nm) of bis-ANS (4.7 μM) incubated with NBV (solid lines) or ARV
(dashed lines) p10ecto peptides (80 μM) with or without TCEP (5 μM). Values are background-subtracted averages of four replicates. (C) As in panel B, using the NBV p10ecto peptide or
the NBV p10C5Secto peptide in the presence or absence of TCEP. (D) OD350 measurements of the ARV p10ecto peptide in aqueous conditions over time with and without DTT.
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as theβ-amyloid (Aβ) peptide [42]. It is possible that localized “drying” of
exposed hydrophobic residues and a concomitant increase in the hydra-
tion density around nearby hydrophilic residues delays hydrophobic
aggregation of the p10 ectodomain peptide. The sigmoidal aggregation
kinetic proﬁle is also consistent with a nucleation-and-growth process,
with weak associations between monomeric peptides slowly generating
oligomeric nuclei that subsequently grow into higher-order aggregates
[43,44].
Regardless of the mechanism of p10 peptide aggregation, the bis-
ANS and aggregation results are both consistent with the p10 intramo-
lecular disulﬁde bond increasing exposure of hydrophobic residues. In
addition, previous studies indicated that ARV p10 is rapidly degraded
following co-translational insertion into the endoplasmic reticulum
membrane compartment [45]. Substitution of either cysteine residue
eliminated rapid p10 degradation, as did substitutions that modestly
decreased FP hydrophobicity (V15M or V19M), suggesting exposed
hydrophobic residues target p10 to the cellular quality control degrada-
tion machinery. Most importantly, while decreased FP hydrophobicity
increased p10 stability, p10 cell–cell fusion activity was abrogated
[45]. Taken together, the present and previous results all suggest the
cystine loop functions as a cystine noose, forcing solvent exposure of
hydrophobic residues that are required for membrane fusion activity.
3.2. NMR analysis suggests the CM adopts an α-helical structure
Peptide aggregation precluded NMR structural analysis of the cystine
loop-containing peptide under aqueous conditions, and structural analy-
sis of the reduced form of the peptide would be of little value since this
state of p10 is not able to induce cell–cell fusion [24]. The ARV p10ectoTr
peptide was soluble in two different organic solvents, DMSO and HFIP,
and in two different membrane-mimetic environments, SDS and DPCmicelles. In the course of TOCSY and NOESY analysis by the sequential
assignment strategy, it became clear that the NMR spectra exhibited an
insufﬁcient number of spin systems to be consistent with the amino
acid composition of the peptide in each of the tested conditions
(Fig. 2A). Assignment of peaks and identiﬁcation of spin systems in the
p10ectoTr peptide in DMSO, which displayed the maximum number of
peaks with reasonable intensities, allowed unambiguous identiﬁcation
of only nine of 33 residues. Interestingly, these residues, Ala28–Ser36,
correspond to the CM (Fig. 1A). Spin systems corresponding to the
remaining residues were either undetectable in the NMR spectra (15
residues) or could only be ambiguously assigned (9 residues) due to
lack of sequential correlations in the NOESY spectrum. The 1H chemical
shifts of the assigned amino acids are shown in Supplementary Table S1.
The lack of observable NMR spin systems for regions of the peptide,
while other regions were fully observable, indicate the peptide was
undergoing intermediate exchange on the NMR time-scale (i.e., on the
order of milliseconds [46]) in all examined conditions. Possible sources
may be dynamic exchange between monomer and oligomer states,
between free andmicelle-bound states, and/or conformational exchange
of the polypeptide at the millisecond time scale. Similar NMR signal loss
has been reported in other systems, for example with the aggregation
prone Aβ amyloid and α-synuclein peptides in the presence of small
hydrophobic molecules or surfactants [47–49]. The unambiguously
assigned amino acids corresponding to the CM indicated this region was
not undergoing such conformational exchange in DMSO. Presumably,
the observable NMR signals in HFIP, SDS and DPC were also mostly
from this region of the peptide.
Negative Δδ values for Hα nuclei over all residues in the assigned
Ala28–Ser36 range (Fig. 2B) suggest that this region has α-helical
propensity [34,50]. Recent studies indicate the CM functions as a
p10 multimerizationmotif [27], andwhile not conclusive, a helical pro-
pensity in the CM is suggestive that p10 assembly into higher order
Fig. 2. The p10 ectodomain conservedmotif showsα-helical propensity. (A) Hα-HN region of the 2D 1H–1H TOCSY of ARV p10ectoTr in two organic solvents and twomicellar environments.
Spin systems from only a small proportion of the constituent amino acids, out of the 33 total, are observable. Sequential assignments were performed only under DMSO conditions, where the
A28–S36 region was unambiguously assignable. (B) Secondary chemical shifts (Δδ) for Hα resonances, calculated by subtracting the random coil chemical shifts for peptides of sequence
GGXAGG determined in DMSO from those of the p10ectoTr A28–S36 amino acids. The negative Δδ values suggest an α-helical propensity for the corresponding residues.
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We note that this potential helical structure might contribute to the
aggregation phenomenon, similar to hIAPP where α-helical structures
are responsible for weak interactions during the nucleation stage that
are subsequently stabilized by hydrophobic interactions to produce
high-order aggregates [41]. We also note that, while stable p10multimer
formation requires p10 clustering in cholesterol-rich plasma membrane
microdomains [27], associations between exposed hydrophobic residues
in the cystine noose might also contribute to oligomer formation. Thus,
a combination of cystine noose hydrophobic interactions and comple-
mentary CM interactions may promote oligomer formation when the
full-length protein is present in membrane microdomains, but peptide
aggregation when the ectodomain is present by itself in an aqueous
environment.
3.3. Cystine noose formation is required for liposome partitioning and lipid
mixing activity
Studies suggest structural plasticity is a common feature of several
enveloped viral FPs. Structural transitioning from α-helices to β-
sheets has been shown for the FPs of HIV gp41, paramyxovirus F,inﬂuenza HA, and Ebola GP [51–53]. Since a high-resolution, three-
dimensional structure of the p10 ectodomain was not determinable by
NMR, the functional implications of the p10 disulﬁde bondwere assessed
by other means. Using far-ultraviolet CD spectroscopy, we measured the
global secondary structure characteristics of ARV p10ecto under both
oxidized and reduced conditions in aqueous and liposome environments
(Fig. 3A). The reduced p10ecto peptide displayed nearly identical spectra
in an aqueous environment and in the presence of liposomes (Fig. 3A),
implying the same overall conformation under both conditions. These
spectra were quite distinct from the spectra obtained for the non-
reduced p10ecto peptide under both conditions (Fig. 3A). While changes
in peptide solubility could contribute to changes in the CD spectra of the
different peptides under different conditions, the relatively long-term
(N5 h) solubility of high concentration peptide (0.5 mM) and the
substantial differences in CD spectra following short-term (b1 h) incu-
bation of low concentration peptide (0.01mM) suggest that differences
in the CD spectra at least partially reﬂect differences in peptide struc-
ture. Together, these results suggest that the disulﬁde bond induces
structuring within the p10 ectodomain required either for lipid-induced
structural changes in the peptide or increased lipid-mediated peptide
solubility.
Fig. 3. An intramolecular disulﬁde bond is required for membrane binding and lipid mixing activity of the p10 ectodomain fusion peptide. (A) CDmeasurements of the ARV p10ecto syn-
thetic peptide in aqueous and liposome conditions, with and without DTT. (B) Silver-stained tricine gel showing partitioning of the p10ecto peptide into liposomes composed of
40:30:20:10 DOPC:DOPE:Chol:Sph, in the absence (lane 2) or presence (lane 3) of DTT. Input peptide (lane 1), input peptide treated with DTT (lane 4) and liposomes treated with DTT
(lane 5) are included as controls. (C) Liposome lipid mixing activity of the ARV p10ecto peptide with and without DTT showing raw ﬂuorescence data (left) andmean+/− standard de-
viation of % lipid mixing from four replicates (right). Theoretical maximum ﬂuorescence from 0.2% NBD- and Rho-labeled liposomes is shown with raw data.
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into liposomes, ARV p10ecto in the oxidized and reduced states was
mixed with liposomes and liposomes were subsequently separated
from free peptide by ﬂotation on sucrose-density gradients. The
liposome-associated peptide in the liposome fraction from sucrose
gradients was detected by SDS-tricine gel electrophoresis and silver
staining. The oxidized ARV p10ecto peptide containing the cystine
noose avidly partitioned into liposomes, and this partitioning was lost
when the peptide was reduced using DTT (Fig. 3B).
ARV p10ectowas also analyzed for lipidmixing activity using a com-
monly employed ﬂuorescence resonance energy transfer (FRET) based
liposome assay [35]. In this assay, exogenous peptide is added to a 9:1
mixed population of unlabeled to NBD/rhodamine ﬂuorescently-
labeled liposomes (peptide:lipid ratio of 1:10). Lipid mixing between
the labeled and unlabeled liposomes is detected by changes in FRET,
measured as intensiﬁed NBD emission as the average spatial separation
of theNBD/rhodamine FRET pair is increased uponmixing of the labeled
and unlabeled liposomes. As shown (Fig. 3C), cystine noose-containing
ARV p10ecto induced rapid and robust lipid mixing, while reduced
versions of this peptide induced lipid mixing at levels only slightly
above background. To ensure the reducing agent had no effect on the
FRET assay, this assay was repeated in the absence of peptide, using
increasing concentrations of Triton X-100 to induce partial liposome
solubilization and lipid mixing. The presence of DTT had no effect on
NBD emission (Supplementary Fig. 1). Thus, the cystine noose FP is
required for p10 ectodomain partitioning into lipid bilayers and for
p10-mediated lipid bilayer destabilization.
3.4. Lipid mixing occurs in the absence of detectable liposome tubulation
FPs present in protein components of the intracellular vesicle fusion
machinery induce liposome-liposome fusion by generating liposome
tubules with highly curved, fusogenic lipidic end caps [12,15]. A similarfusion mechanism for enveloped virus FPs has not been demonstrated.
To determine whether the lipid mixing activity of the p10 ectodomain
FP reﬂects formation of fusogenic liposome tubules, ARV and NBV
p10ecto peptides (10 μM)were incubatedwith 100 nm liposomes com-
posed of 40:30:20:10 DOPC:DOPE:Chol:Sph at a 1:10 peptide:lipid
molar ratio, the same conditions under which lipid mixing was ob-
served (Fig. 3C). Liposome size and morphology were examined using
electron microscopy. For both the ARV and NBV peptides, there was a
visible increase in the size of roughly spherical liposomes following
lipid mixing but liposome tubules were undetectable by electron
microscopy (Fig. 4B). The diameters of approximately 900 liposomes
from two independent experiments were measured, and liposomes
were binned into size classes. When analyzed as percent liposomes in
each bin size, or as percent total liposome volume in each bin size,
there was a clear increase in the number of liposomes in the larger bin
sizes (Fig. 4A). Correspondingly, the mean liposome volume increased
from 466 μm3 for control liposomes to 739 μm3 or 929 μm3 for lipo-
somes in the presence of ARV or NBV ectodomain peptide, respectively.
The p10 cystine noose FP therefore induces liposome fusion in the
absence of liposome tubulation.
In contrast to the extremely rapid kinetics of p10-induced lipid
mixing occurring in the absence of liposome tubulation shown here,
lipid mixing occurs more gradually (~several minutes) in similar
FRET-based assays of tubulation-dependent liposome fusion mediated
by components of intracellular vesicle fusion complexes [12,15]. One
possible explanation for these differences is peptide:lipid ratios: our
assays used a 1:10 ratio while tubulation and lipid mixing assays with
Doc2b and the N-BAR domain of endophilin used ratios of ~1:50–
1:200. However, we recently demonstrated that peptide:lipid ratios of
1:20 reduced the overall extent, but not the rate, of lipidmixing induced
by the ARV and NBV p10ecto peptides [27], suggesting peptide:lipid
ratios are unlikely to account for p10-induced liposome fusion in the
absence of liposome tubulation. Regardless of the explanation for the
Fig. 4. The ARV and NBV p10ecto peptides induce liposome lipidmixing in the absence of liposome tubulation. (A) Liposome size distributions following ARV or NBV p10ecto peptide-induced
liposome lipid mixing. Results are presented as % of total liposome counts (top) and % of total liposome volume (bottom) relative to control liposomes for each liposome diameter bin size.
(B) Representative EM images of negatively-stained control liposomes and liposomes incubated with ARV p10ecto or NBV p10ecto. Scale bar = 500 nm.
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vesicle FPs, the p10 cystine noose FP can clearly induce liposome fusion
in the absence of liposome tubulation.
3.5. Cholesterol stimulates p10 FP-induced lipid mixing
Lipid composition can have profound effects on the fusion activity of
FPs. For example, Chol levels directly inﬂuence the structure and lipid
mixing activity of the HIV gp41 FP [54]. We therefore assessed the
lipid mixing activity of ARV p10ecto using liposomes composed of
DOPC:DOPE:Chol:Sph in various molar ratios. For all experiments, the
mol % of DOPE was kept constant at 30% while that of DOPC was varied
with Chol or Sph, as indicated.When varying Chol, themol % of Sphwas
kept at 10%. Similarly, when varying the amount of Sph, the mol % of
Chol was kept at 20%. Under these various conditions, there was a sub-
stantial increase in lipid mixing as Chol content was raised from 0–10%
(P b 0.0001) and 10–20% (P = 0.0005), but no statistically signiﬁcant
increase in lipid mixing occurred as Chol was raised from 20–30%
(P= 0.2227, Fig. 5A). An increase in lipidmixing activitywith increased
mol % Cholwas not observed for the low level of lipidmixing induced by
the reduced ARV p10ecto peptide (P = 0.389, Fig. 5B), indicating thatthe presence of Chol does not simply alter the overall fusogenicity of
the membrane. In contrast, changes in Sph content had only modest,
though statistically signiﬁcant, effects on p10-induced liposome fusion,
which increased from 0–10% Sph (P = 0.0007), but decreased from
10–20% Sph (P = 0.0034) and 20–30% Sph (P = 0.0007) (Fig. 5C).
Membrane fusion mediated by the p10 cystine noose FP is therefore
enhanced in Chol-containing membranes.
Previous studies have shown that increasing Chol content increases
the ability of the HIV gp41 FP to induce lipid mixing, which is accompa-
nied by a structural transition from anα-helical to β-sheet conformation
[54]. Such was not the case for the ARV p10ecto peptide, as indicated
by the near identical CD spectra obtained in the presence of liposomes
containing a 0-30 mol% range of Chol (Fig. 5D). The presence of Chol in
membranes has also been implicated in the binding and insertion of
the Semliki Forest virus FP into target membranes [55]. Again, such
was not the case for ARV p10ecto peptide; liposome partitioning of
p10ecto was unaffected by the absence of cholesterol in liposomes
(Fig. 5E), assessed using the same liposome partitioning experiment
previously used to show peptide partitioning into liposomes containing
20 mol% Chol (Fig. 3B). As with Chol-containing liposomes, peptide
partitioning into Chol-free liposomes was dependent on the presence
Fig. 5. Cholesterol inﬂuences the lipid mixing activity of p10ecto peptide. (A and B) Liposome lipid mixing activity of ARV p10ecto peptide in the absence (A) or presence (B) of DTT with
liposomes of the indicated Chol content. (C) Liposome lipid mixing activity of ARV p10ecto peptide with liposomes of the indicated Sph content. (D) CD measurements of the ARV p10ecto
peptide incubated with liposomes of varying Chol content. (E) Silver-stained tricine gel showing partitioning of the p10ecto peptide into liposomes composed of 60:30:0:10 DOPC:DOPE:
Chol:Sph in the absence (lane 2) or presence (lane 3) of DTT. Input peptide (lane 1), input peptide treated with DTT (lane 4) and liposomes treated with DTT (lane 5) are included as controls.
415T. Key et al. / Biochimica et Biophysica Acta 1848 (2015) 408–416of the cystine noose (Fig. 5E). Thus, Chol does not inﬂuence membrane
partitioning of the p10 cystine noose FP, but instead has a direct inﬂuence
on p10 FP-induced membrane fusion activity.
Chol may inﬂuence p10-mediated membrane fusion in several ways.
As a prerequisite to lipid mixing and fusion stalk formation, two bilayers
must be closely apposed. At these short separation distances, repulsive
“hydration forces” dominate [56]. The presence of Chol facilitates mem-
brane dehydration, thus promoting membrane contact and fusion [57].
The HIV gp41 and inﬂuenza virus HA FPs have been shown to increase
the order ofmembranes in a Chol-dependent fashion, with Chol inﬂuenc-
ing the overall fusogenicity by both altering the insertion depth of FPs and
maximizing the dehydration effect at the site of fusion [54,58]. Addition-
ally, themolecular shape of Chol has been suggested to promote negative
curvature in the outer bilayer leaﬂet [59], which can increase the forma-
tion of fusion intermediates by lowering the energy barriers of transition
states. Additional studies are needed to determine whether these, or
other, effects of Chol on membranes contribute to the demonstrated
Chol-dependent fusion activity of the p10ecto FP.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbamem.2014.10.020.
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